Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters.
Zacks.com on MSN
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.
ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore ...
Onward Medical N.V. ( OTC:ONWRF) Q3 2025 Earnings Call November 24, 2025 8:00 AM EST ...
The internal neuromodulation devices market is surging, powered by personalized AI and smaller hardware. As these smart, ...
The ability of these devices to access aspects of a person’s innermost life, including preconscious thought, raises the ...
Internal neuromodulation devices market size was valued at US$ 11.81 billion in 2024 and is projected to hit the market valuation of US$ 44.57 billion by 2033 at a CAGR of 15.9% during the forecast ...
ONWARD Medical, N.V. has received expanded FDA 510 (k) clearance for home use of the ARC-EX System, its non-invasive spinal cord stimulation therapy designed to improve strength and sensation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback